SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.35
-0.04 (-2.88%)
As of Mar 22, 10:25 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,096.3% upside
Low Target $10.52
Average Target $16.15
High Target $19.28
Current Price $1.35
Current
$1.35
Target
$16.15
$10.52 $16.15 avg $19.28
Scenario Analysis
Bear Case
$10.52
679.3%
Low target
Base Case
$16.15
+1,096.3%
Avg target
Bull Case
$19.28
+1,328.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.89
-53.3% from high
52-Week Low
$1.15
+17.4% from low
Target vs 52W High
$16.15
+458.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%